פרק 10: מהן ההשפעות השליליות 'המתונות' של התרופות הממריצות?

רשימת מקורות

1. Dodson W. How Safe Are ADHD Medications? : ADDitude. The author is a member of the ADDitude Medical Advisory Panel. Last retrieved on May 8, 2023, from: https://www.additudemag.com/is-adhd-medication-safe-doctor-william-dodson-says-yes/; 2023.
2. ברק י. טעים ומתוק – ספיישל באורך מלא. יוטיוב. נדלה לאחרונה בתאריך 26.6.24 מאתר: https://www.youtube.com/watch?v=u4Y3U-D0vmQ; 2018.
3. Storebø OJ, Pedersen N, Ramstad E, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies. Cochrane Database of Systematic Reviews. 2018;(5)
4. Elliott J, Johnston A, Husereau D, et al. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLoS One. 2020;15(10):e0240584.
5. Swanson JM, Arnold LE, Molina BSG, et al. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. Journal of Child Psychology and Psychiatry. 2017/06/01 2017;58(6):663-678. doi:10.1111/jcpp.12684
6. Swanson J, Arnold LE, Kraemer H, et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children with ADHD (MTA) Part I: Executive Summary. Journal of Attention Disorders. 2008;12(1):4-14.
7. Greenhill LL, Swanson JM, Hechtman L, et al. Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2020/08/01/ 2020;59(8):978-989. doi:https://doi.org/10.1016/j.jaac.2019.06.019
8. Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R. Stimulant treatment over 5 years: effects on growth. Journal of the American Academy of Child & Adolescent Psychiatry. 2006;45(4):415-421.
9. Troksa K, Kovacich N, Moro M, Chavez B. Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review. https://doi.org/10.1002/phar.2192. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2019/06/01 2019;39(6):665-676. doi:https://doi.org/10.1002/phar.2192
10. Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight: a review of the literature. Journal of the American Academy of Child & Adolescent Psychiatry. 2008;47(9):994-1009.
11. Vitiello B. Long-Term Effects of Stimulant Medications on the Brain: Possible Relevance to the Treatment of Attention Deficit Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 2001/03/01 2001;11(1):25-34. doi:10.1089/104454601750143384
12. נובורטיס ישראל. עלון לצרכן לפי תקנות הרוקחים של תרופת הריטלין. נובורטיס פארמה, בזל, שווייץ. עלון זה נבדק ואושר על-ידי משרד הבריאות בפברואר 2017.; 2017.
13. Aarskog D, Fevang FØ, Kløve H, Støa KF, Thorsen T. The effect of the stimulant drugs, dextroamphetamine and methylphenidate, on secretion of growth hormone in hyperactive children. The Journal of Pediatrics. 1977/01/01/ 1977;90(1):136-139. doi:https://doi.org/10.1016/S0022-3476(77)80788-9
14. Konrad-Bindl DS, Gresser U, Richartz BM. Changes in behavior as side effects in methylphenidate treatment: review of the literature. Neuropsychiatric disease and treatment. 2016;12:2635.
15. Rasmussen N. Medical Science and the Military: The Allies' Use of Amphetamine during World War II. The Journal of Interdisciplinary History. 2011;42(2):205-233. doi:10.1162/JINH_a_00212
16. אופיר י. הסמים שהמחבלים לקחו העניקו להם חוסר פחד – את האכזריות הם הביאו מהבית. מקור ראשון. נדלה לאחרונה בתאריך 27.5.2024 מאתר: https://www.makorrishon.co.il/opinion/694281/; 2023.
17. Moore TJ, Glenmullen J, Furberg CD. Prescription drugs associated with reports of violence towards others. PloS one. 2010;5(12):e15337.
18. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of metlyiphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics. 1990;86(2):184-192.
19. צור מ. השפעת היענות לטיפול תרופתי בהפרעות קשב וריכוז על צריכת שירותי רפואה ותפקוד תעסוקתי בקרב חיילי צה"ל. אוניברסיטת בר אילן. עבודה שהוגשה כחלק מהדרישות לשם קבלת תואר מוסמך במחלקה לניהול. בהדרכתה של ד"ר רחלי מגנזי. נדלה לאחרונה בתאריך 11.9.2023 מאתר: https://biu.primo.exlibrisgroup.com/discovery/fulldisplay/alma990024216310205776/972BIU_INST:BIThe; 2015.
20. Eisenberg L. Commentary with a historical perspective by a child psychiatrist: when "ADHD" was the "brain-damaged child". 2007;(1044-5463 (Print))
21. Ophir Y. Reconsidering the Safety Profile of Stimulant Medications for ADHD. Ethical Human Psychology and Psychiatry. 2022;24(1):41-50. doi:10.1891/EHPP-2021-0007
22. Currie J, Stabile M, Jones L. Do stimulant medications improve educational and behavioral outcomes for children with ADHD? Journal of health economics. 2014;37:58-69.
23. Breggin PR. Rational principles of psychopharmacology for therapists, healthcare providers and clients. Journal of Contemporary Psychotherapy. 2016;46(1):1-13.
24. Mayes SD, Crites DL, Bixler EO, Humphrey FJ, Maltison RE. Methylphenedate and ADHD: Influence of Age, IQ and Neurodevelopmental Status. Developmental Medicine & Child Neurology. 1994;36(12):1099-1107.
25. Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G. Effects of stimulant medication on learning in children with ADHD. Journal of Learning Disabilities. 1991;24(4):219-230.
26. Fiedler NL, Ullman DG. The effects of stimulant drugs on curiosity behaviors of hyperactive boys. Journal of abnormal child psychology. 1983;11(2):193-206.
27. Granger DA, Whalen CK, Henker B. Perceptions of methylphenidate effects on hyperactive children's peer interactions. Journal of Abnormal Child Psychology. 1993;21(5):535-549.
28. Sax L. Boys adrift: The five factors driving the growing epidemic of unmotivated boys and underachieving young men. Basic Books; 2016.
29. Breggin PR. Psychiatric Drug Withdrawal : A Guide for Prescribers, Therapists, Patients and Their Families. Springer Publishing Company; 2013.
30. Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. Journal of Child and Adolescent Psychopharmacology. 1998;8(1):13-25.
31. Cunningham CE, Barkley RA. The Effects of Methylphenidate on the Mother‐child Interactions of Hyperactive Identical Twins. Developmental Medicine & Child Neurology. 1978;20(5):634-642.
32. Fogelman Y, Vinker S, Guy N, Kahan E. Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period. CNS drugs. 2003;17(12):915-919.
33. APA. Diagnostic and Statistical Manual of  Mental Disorders, 5th edition, Text Revision (DSM-5-TR). American Psychiatric Association.  Washington, DC; 2022.
34. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European psychiatry. 2019;56:14-34.
35. Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics. 2015;136(6):1144-1153.
36. Nutt D, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues in clinical neuroscience. 2008;10(3):329-336. doi:10.31887/DCNS.2008.10.3/dnutt
37. Steiger A, Pawlowski M. Depression and Sleep. International Journal of Molecular Sciences. 2019;20(3)doi:10.3390/ijms20030607
38. Cherland E, Fitzpatrick R. Psychotic side effects of psychostimulants: a 5-year review. The Canadian Journal of Psychiatry. 1999;44(8):811-813.
39. Borcherding BG, Keysor CS, Rapoport JL, Elia J, Amass J. Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability? Psychiatry Research. 1990;33(1):83-94.
40. Gokcen C, Karadag M, Aksoy I. Methylphenidate Induced Lip and Tongue Biting. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. 2018;16(2):218-220. doi:10.9758/cpn.2018.16.2.218
41. Biederman J, DiSalvo M, Green A, et al. How Frequent Is Switching From an Initial Stimulant Family to the Alternative One in the Clinical Setting?: A Pilot Study of 49 Consecutively Referred Medication-Naive Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology. 2021;41(3):310-314.
42. Ophir Y. Reconsidering the Safety Profile of Stimulant Medications for ADHD. Ethical Human Psychology and Psychiatry. 2022;24-1
43. Spinka M, Newberry RC, Bekoff M. Mammalian play: training for the unexpected. The Quarterly review of biology. 2001;76(2):141-168.
44. Breggin P. What psychologists and therapists need to know about ADHD and stimulants. CHANGES-SHEFFIELD-. 2000;18(1):13-23.
45. Castner SA, Goldman-Rakic PS. Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology. 1999;20(1):10-28.
46. Castner SA, Williams GV. From vice to virtue: Insights from sensitization in the nonhuman primate. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2007/11/15/ 2007;31(8):1572-1592. doi:https://doi.org/10.1016/j.pnpbp.2007.08.026

בחזרה לעמוד הראשי של רשימת המקורות של הספר, לחצו כאן.